Litigation Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
✉ Email this page to a colleague
LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-05-06 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Sue Lewis Robinson |
| Jury Demand | None | Referred To | Judge Sherry R. Fallon |
| Patents | 7,410,656; 8,278,292; 8,372,827; 8,372,828; 8,377,919; 8,536,163; 8,716,271; 8,735,375 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in LEO Pharma A/S v. Actavis Laboratories UT, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for LEO Pharma A/S v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-02-26 | 266 | infringement often patents: U.S. Patent Nos. 7,410,656 ("the '656 patent"), 8,278,292 (…163 patent"), 8,716,271 ("the '271 patent"), 8,735,375 ("the '375 patent"…the "patents-in-suit"). (Id at ,r 8) The '084 patent and the '698 patent, identified…prior art U.S. Patent No. 7,378,445 ("the '445 patent") to the U.S. Patent and Trademark … entire patent portfolio, including the '445 patent and U.S. Patent No. 7,449,492 ("the ' | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
